Single nucleotide polymorphisms at the ADIPOQ gene locus interact with age and dietary intake of fat to determine serum adiponectin in subjects at risk of the metabolic syndrome

American Journal of Clinical Nutrition

Volumn 94, Issue 1, 2011, Pages 262-269

  AlSaleh, Aseel ^a   O'Dell, Sandra D ^a   Frost, Gary S ^b   Griffin, Bruce A ^c   Lovegrove, Julie A ^d   Jebb, Susan A ^e   Sanders, Thomas A B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d UNIVERSITY OF READING   (United Kingdom)

^e MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CARBOHYDRATE; FAT; MONOUNSATURATED FATTY ACID; SATURATED FATTY ACID;

ADIPOQ GENE; AFRICA; ARTICLE; ASIA; BODY MASS; CLINICAL TRIAL; DIETARY INTAKE; ETHNICITY; EUROPEAN AMERICAN; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NUTRITIONAL ASSESSMENT; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SEX; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; ADULT; AGE FACTORS; AGED; BODY MASS INDEX; CHROMOSOME MAPPING; DIETARY FATS; FATTY ACIDS, MONOUNSATURATED; FEMALE; GENOTYPE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 79959462961     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.014209     Document Type: Article

References (43)

1. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005;56:45-62. (Pubitemid 40299773)
2. Risérus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009;48:44-51.
3. Corella D, Ordovas JM. Single nucleotide polymorphisms that influence lipid metabolism: Interaction with dietary factors. Annu Rev Nutr 2005;25:341-90. (Pubitemid 41209006)
4. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288-95. (Pubitemid 35373562)
5. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-6. (Pubitemid 32756432)
6. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83. (Pubitemid 29299050)
7. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-5. (Pubitemid 32472900)
8. Duncan BB, Schmidt MI, Pankow JS, et al. Adiponectin and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes 2004;53:2473-8. (Pubitemid 39145606)
9. Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004;68:975-81. (Pubitemid 39540124)
10. Comuzzie AG, Funahashi T, Sonnenberg G, et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 2001;86:4321-5. (Pubitemid 32848553)
11. Hara K, Boutin P, Mori Y, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002;51:536-40. (Pubitemid 34764814)
12. Menzaghi C, Ercolino T, Di Paola R, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002;51:2306-12. (Pubitemid 34729040)
13. Vasseur F, Helbecque N, Dina C, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone concentrations and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002;11:2607-14. (Pubitemid 35174690)
14. Bouatia-Naji N, Meyre D, Lobbens S, et al. ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes 2006;55:545-50. (Pubitemid 43343288)
15. Heid IM, Wagner SA, Gohlke H, et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma concentrations and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 2006;55:375-84. (Pubitemid 43343266)
16. Filippi E, Sentinelli F, Trischitta V, et al. Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet 2004;12:199-205. (Pubitemid 38499978)
17. Ohashi K, Ouchi N, Kihara S, et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol 2004;43:1195-200. (Pubitemid 38452596)
18. Vozarova de Courten B, Hanson RL, Funahashi T, et al. Common polymorphisms in the adiponectin gene ACDC are not associated with diabetes in Pima Indians. Diabetes 2005;54:284-9. (Pubitemid 40105124)
19. Pischon T, Girman CJ, Rifai N, Hotamisligil GS, Rimm EB. Association between dietary factors and plasma adiponectin concentrations in men. Am J Clin Nutr 2005;81:780-6. (Pubitemid 41724983)
20. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289:1799-804. (Pubitemid 37430249)
21. Kasim-Karakas SE, Tsodikov A, Singh U, Jialal I. Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake. Am J Clin Nutr 2006;83:774-9. (Pubitemid 44713139)
22. Lithander FE, Keogh GF, Wang Y, et al. No evidence of an effect of alterations in dietary fatty acids on fasting adiponectin over 3 weeks. Obesity (Silver Spring) 2008;16:592-9. (Pubitemid 351328010)
23. Paniagua JA, Gallego de la Sacristana A, Romero I, et al. Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Diabetes Care 2007;30:1717-23. (Pubitemid 47036342)
24. Jebb SA, Lovegrove JA, Griffin BA, et al. Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am J Clin Nutr 2010;92:748-58.
25. Ferré P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004;53(suppl 1):S43-50.
26. Iwaki M, Matsuda M, Maeda N, et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003;52:1655-63. (Pubitemid 36792453)
27. Maeda N, Takahashi M, Funahashi T, et al. PPAR{gamma} ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001;50:2094-9. (Pubitemid 33643677)
28. Kyriakou T, Collins LJ, Spencer-Jones NJ, et al. Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. J Hum Genet 2008;53:718-27.
29. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469-80.
30. Moore C, Gitau R, Goff L, et al. Successful manipulation of the quality and quantity of fat and carbohydrate consumed by free-living individuals using a food exchange model. J Nutr 2009;139:1534-40.
31. NCBI. Entrez SNP. Available from: http://www.ncbi.nlm.nih.gov/snp build 132 (cited 11 November 2010).
32. Adamczak M, Rzepka E, Chudek J, Wiecek A. Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf) 2005;62:114-8. (Pubitemid 40175291)
33. Marques-Vidal P, Bochud M, Paccaud F, Mooser V, Waeber G, Vollenweider P. Distribution of plasma concentrations of adiponectin and leptin in an adult Caucasian population. Clin Endocrinol (Oxf) 2010;72:38-46.
34. Cohen SS, Gammon MD, Signorello LB, et al. Serum adiponectin in relation to body mass index and other correlates in black and white women. Ann Epidemiol 2011;21:86-94.
35. Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA. Ethnic differences in adiponectin concentrations. Metabolism 2004;53:1-3.
36. Qi L, Li T, Rimm E, et al. The +276 polymorphism of the APMI gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005;54:1607-10. (Pubitemid 40586698)
37. Woo JG, Dolan LM, Deka R, et al. Interactions between noncontiguous haplotypes in the adiponectin gene ACDC are associated with plasma adiponectin. Diabetes 2006;55:523-9. (Pubitemid 43343285)
38. Hu FB, van Dam RM, Liu S. Diet and risk of Type II diabetes: the role of types of fat and carbohydrate. Diabetologia 2001;44:805-17. (Pubitemid 32642452)
39. Yeung EH, Appel LJ, Miller ER III, Kao WH. The effects of macronutrient intake on total and high-molecular weight adiponectin: results from the OMNI-Heart trial. Obesity (Silver Spring) 2010;18:1632-7.
40. Ferguson JF, Phillips CM, Tierney AC, et al. Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance. Am J Clin Nutr 2010;91:794-801.
41. Sanderson LM, de Groot PJ, Hooiveld GJ et al. Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics. PLoS One 2008;3:e1681.
42. Pérez-Martínez P, López-Miranda J, Cruz-Teno C, et al. Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. J Nutr 2008;138:1609-14.
43. Warodomwichit D, Shen J, Arnett DK, et al. ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. Obesity (Silver Spring) 2009;17:510-7.